Figure 3: Effect of GSH/PC, CUR/RES, DHA treatments and various combinations on Aβ25-35 oligomeric peptide induced impairment of escape latency in the step through passive avoidance test. n is between 9 and 12 depending on the groups; ** p < 0.01, *** p < 0.0001 vs. the Sc.Aβ group, ### p < 0.001 vs. the Aβ25-35 group; Dunn's test.

figure 3